UNITY Biotechnology
Biotechnology company devoted to research of restoring human health
UNITY Biotechnology is developing therapeutics to extend healthspan by slowing, halting or reversing diseases of aging. UNITY's initial focus is on creating senolytic medicines to selectively eliminate senescent cells and thereby treat age-related diseases, such as osteoarthritis, eye diseases and pulmonary diseases.
Working at the frontier of biotechnology and medicine, our mission is to develop therapeutics to extend the period of one’s life unburdened by disease. Our initial focus is on delivering localized therapy in ophthalmologic diseases, including diabetic macular edema and age-related macular degeneration, and age-related neurologic conditions.
Visit website: https://unitybiotechnology.com/
Details last updated 04-Feb-2019
People at UNITY Biotechnology
UNITY Biotechnology News
UNITY Biotech's lead compound lags behind the Regeneron’s eye drug
Biospace - 27-May-2023
UBX1325 showed disappointing results in phase II macular degeneration trial - further analysis is required
Read more...Unity Biotechnology's diabetic macular edema senolytic treatment shows promise at 48-week endpoint
FierceBiotech - 24-Apr-2023
Corporate shift towards ophthalmology puts senolytics head-to-head against existing treatments
Read more...Data from Phase 2 BEHOLD study of UBX1325 in DME patients-Unity Biotechnology
Ophthalmology Times - 12-Aug-2022
Statistically significant treatment effect for both BCVA and CST was seen at both 12 and 18 weeks
Read more...Longevity.Technology looks at 12 key companies running age-related disease clinical trials in 2021
Longevity Technology - 25-Feb-2022
Approaches include senotherapeutics, stem cells and mitochondria. Eye disease is a common first target.
Read more...Longevity Technology interviews Aubrey de Grey about senolytics and other senotherapeutics
Longevity Technology - 05-Aug-2021
Most approaches have their limitations but good progress is being made on several fronts
Read more...Unity's senolytic drug reports positive phase 1 data in eye disease patients
FierceBiotech - 06-Jul-2021
Begun phase 2 trial including patients with early stage of disease to test its safety and effectiveness
Read more...Super summary of 3rd Annual Longevity Therapeutics Summit
Lifespan.io (LEAF) - 16-Feb-2021
More and more companies making greater and greater progress - 2021 could be an exciting year
Read more...LMC provides background and success outlook on 14 leading senolytic companies
Longevity Marketcap - 15-Dec-2020
Comprehensive review of companies' clinical and financial state of play
Read more...Unity Biotechnology launches clinical trial of a new senolytic
Lifespan.io (LEAF) - 13-Oct-2020
A new approach to treat diabetic macular oedema
Read more...Labiotech gathers feedback from European biotechs on Unity failure
Labiotech - 28-Aug-2020
General feeling that failures are bound to happen - but that their approaches can succeed
Read more...Reason examines the failure of Unity Biotechnology's phase 2 senolytics trial
Fight Aging! - 18-Aug-2020
Disappointing first result - but lessons learnt and plenty of other strategies available
Read more...Research into klotho is at a very interesting point
Fight Aging! - 03-Jun-2019
Research community is littered with interesting, promising foundations for therapies to treat aging
Read more...UNITY Biotechnology expands trial of osteoarthritis senolytic
UNITY Biotechnology - 22-Jan-2019
Initial results must be promising to enrol more patients at highest dosage
Read more...UNITY Biotechnologies Selects a New Senolytic Candidate
Lifespan.io (LEAF) - 14-Jan-2019
Very early days but good to have more senolytics in the pipeline
Read more...The path to an extended health span and a healthier death
MIT Technology Review - 23-Oct-2018
Still a long way to go before expanding life span
Read more...Cleara Biotech Joins the Race to Develop Senolytic Therapies
Lifespan.io (LEAF) - 09-Jul-2018
This therapy uses a modified FOXO4 to promote apoptosis in senescent cells
Read more...Silicon Valley and rich people invest to slow down ageing and live longer
This Is Money - 17-Mar-2018
All the money in the world to fight ageing and death
Read more...SRF has made progress in the fight against ageing
Lifespan.io (LEAF) - 05-Dec-2017
R&D phase in SENS repair approach has shown promising results
Read more...Here are the ways Silicon Valley plans to conquer death
National Post - 03-Nov-2017
Billionaires are now pouring millions into longevity research. Upgrading the human immune system...
Read more...To stay young, kill zombie cells
Nature - 24-Oct-2017
Proof-of-concept trials starting that pit senolytic drugs against a range of age-related ailments...
Read more...Display all news
